Top

Published in:

01-07-2020 | Glioblastoma | Review

Radiomics in gliomas: clinical implications of computational modeling and fractal-based analysis

Authors: Kevin Jang, Carlo Russo, Antonio Di Ieva

Published in: Neuroradiology | Issue 7/2020

Abstract

Radiomics is an emerging field that involves extraction and quantification of features from medical images. These data can be mined through computational analysis and models to identify predictive image biomarkers that characterize intra-tumoral dynamics throughout the course of treatment. This is particularly difficult in gliomas, where heterogeneity has been well established at a molecular level as well as visually in conventional imaging. Thus, acquiring clinically useful features remains difficult due to temporal variations in tumor dynamics. Identifying surrogate biomarkers through radiomics may provide a non-invasive means of characterizing biologic activities of gliomas. We present an extensive literature review of radiomics-based analysis, with a particular focus on computational modeling, machine learning, and fractal-based analysis in improving differential diagnosis and predicting clinical outcomes. Novel strategies in extracting quantitative features, segmentation methods, and their clinical applications are producing promising results. Moreover, we provide a detailed summary of the morphometric parameters that have so far been proposed as a means of quantifying imaging characteristics of gliomas. Newly emerging radiomic techniques via machine learning and fractal-based analyses holds considerable potential for improving diagnostic and prognostic accuracy of gliomas.

Key points

• Radiomic features can be mined through computational analysis to produce quantitative imaging biomarkers that characterize intra-tumoral dynamics throughout the course of treatment.

• Surrogate image biomarkers identified through radiomics could enable a non-invasive means of characterizing biologic activities of gliomas.

• With novel analytic algorithms, quantification of morphological or sub-regional tumor features to predict survival outcomes is producing promising results.

• Quantifying intra-tumoral heterogeneity may improve grading and molecular sub-classifications of gliomas.

• Computational fractal-based analysis of gliomas allows geometrical evaluation of tumor irregularities and complexity, leading to novel techniques for tumor segmentation, grading, and therapeutic monitoring.

Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: images are more than pictures, they are data. Radiology 278(2):563–577. https://doi.org/10.1148/radiol.2015151169 CrossRefPubMed

Kumar V, Gu Y, Basu S, Berglund A, Eschrich SA, Schabath MB, Forster K, Aerts HJ, Dekker A, Fenstermacher D, Goldgof DB, Hall LO, Lambin P, Balagurunathan Y, Gatenby RA, Gillies RJ (2012) Radiomics: the process and the challenges. Magn Reson Imaging 30(9):1234–1248. https://doi.org/10.1016/j.mri.2012.06.010 CrossRefPubMedPubMedCentral

Zhou M, Chaudhury B, Hall LO, Goldgof DB, Gillies RJ, Gatenby RA (2017) Identifying spatial imaging biomarkers of glioblastoma multiforme for survival group prediction. J Magn Reson Imaging 46(1):115–123. https://doi.org/10.1002/jmri.25497 CrossRefPubMed

Gutman DA, Cooper LA, Hwang SN, Holder CA, Gao J, Aurora TD, Dunn WD Jr, Scarpace L, Mikkelsen T, Jain R, Wintermark M, Jilwan M, Raghavan P, Huang E, Clifford RJ, Mongkolwat P, Kleper V, Freymann J, Kirby J, Zinn PO, Moreno CS, Jaffe C, Colen R, Rubin DL, Saltz J, Flanders A, Brat DJ (2013) MR imaging predictors of molecular profile and survival: multi-institutional study of the TCGA glioblastoma data set. Radiology 267(2):560–569. https://doi.org/10.1148/radiol.13120118 CrossRefPubMedPubMedCentral

Kotrotsou A, Zinn PO, Colen RR (2016) Radiomics in brain tumors: an emerging technique for characterization of tumor environment. Magn Reson Imaging Clin N Am 24(4):719–729. https://doi.org/10.1016/j.mric.2016.06.006 CrossRefPubMed

Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131(6):803–820. https://doi.org/10.1007/s00401-016-1545-1 CrossRefPubMed

Bredel M, Scholtens DM, Harsh GR, Bredel C, Chandler JP, Renfrow JJ, Yadav AK, Vogel H, Scheck AC, Tibshirani R, Sikic BI (2009) A network model of a cooperative genetic landscape in brain tumors. JAMA 302(3):261–275. https://doi.org/10.1001/jama.2009.997 CrossRefPubMedPubMedCentral

Sturm D, Witt H, Hovestadt V, Khuong-Quang D-A, Jones David TW, Konermann C, Pfaff E, Tönjes M, Sill M, Bender S, Kool M, Zapatka M, Becker N, Zucknick M, Hielscher T, Liu X-Y, Fontebasso Adam M, Ryzhova M, Albrecht S, Jacob K, Wolter M, Ebinger M, Schuhmann Martin U, van Meter T, Frühwald Michael C, Hauch H, Pekrun A, Radlwimmer B, Niehues T, von Komorowski G, Dürken M, Kulozik Andreas E, Madden J, Donson A, Foreman Nicholas K, Drissi R, Fouladi M, Scheurlen W, von Deimling A, Monoranu C, Roggendorf W, Herold-Mende C, Unterberg A, Kramm Christof M, Felsberg J, Hartmann C, Wiestler B, Wick W, Milde T, Witt O, Lindroth Anders M, Schwartzentruber J, Faury D, Fleming A, Zakrzewska M, Liberski Pawel P, Zakrzewski K, Hauser P, Garami M, Klekner A, Bognar L, Morrissy S, Cavalli F, Taylor Michael D, van Sluis P, Koster J, Versteeg R, Volckmann R, Mikkelsen T, Aldape K, Reifenberger G, Collins VP, Majewski J, Korshunov A, Lichter P, Plass C, Jabado N, Pfister Stefan M (2012) Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 22(4):425–437. https://doi.org/10.1016/j.ccr.2012.08.024 CrossRefPubMed

Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, Kos I, Batinic-Haberle I, Jones S, Riggins GJ, Friedman H, Friedman A, Reardon D, Herndon J, Kinzler KW, Velculescu VE, Vogelstein B, Bigner DD (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360(8):765–773. https://doi.org/10.1056/NEJMoa0808710 CrossRefPubMedPubMedCentral

10.

Sanson M, Marie Y, Paris S, Idbaih A, Laffaire J, Ducray F, El Hallani S, Boisselier B, Mokhtari K, Hoang-Xuan K, Delattre J-Y (2009) Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas. J Clin Oncol 27(25):4150–4154. https://doi.org/10.1200/JCO.2009.21.9832 CrossRefPubMed

11.

Eckel-Passow JE, Lachance DH, Molinaro AM, Walsh KM, Decker PA, Sicotte H, Pekmezci M, Rice T, Kosel ML, Smirnov IV, Sarkar G, Caron AA, Kollmeyer TM, Praska CE, Chada AR, Halder C, Hansen HM, McCoy LS, Bracci PM, Marshall R, Zheng S, Reis GF, Pico AR, O’Neill BP, Buckner JC, Giannini C, Huse JT, Perry A, Tihan T, Berger MS, Chang SM, Prados MD, Wiemels J, Wiencke JK, Wrensch MR, Jenkins RB (2015) Glioma groups based on 1p/19q, IDH, and TERT promoter mutations in tumors. N Engl J Med 372(26):2499–2508. https://doi.org/10.1056/NEJMoa1407279 CrossRefPubMedPubMedCentral

12.

Jenkins RB, Blair H, Ballman KV, Giannini C, Arusell RM, Law M, Flynn H, Passe S, Felten S, Brown PD, Shaw EG, Buckner JC (2006) A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma. Cancer Res 66(20):9852–9861. https://doi.org/10.1158/0008-5472.CAN-06-1796 CrossRefPubMed

13.

Hegi ME, Liu L, Herman JG, Stupp R, Wick W, Weller M, Mehta MP, Gilbert MR (2008) Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity. J Clin Oncol 26(25):4189–4199. https://doi.org/10.1200/JCO.2007.11.5964 CrossRefPubMed

14.

Delfanti RL, Piccioni DE, Handwerker J, Bahrami N, Krishnan A, Karunamuni R, Hattangadi-Gluth JA, Seibert TM, Srikant A, Jones KA, Snyder VS, Dale AM, White NS, McDonald CR, Farid N (2017) Imaging correlates for the 2016 update on WHO classification of grade II/III gliomas: implications for IDH, 1p/19q and ATRX status. J Neuro-Oncol 135(3):601–609. https://doi.org/10.1007/s11060-017-2613-7 CrossRef

15.

Haas-Kogan DA, Prados MD, Tihan T, Eberhard DA, Jelluma N, Arvold ND, Baumber R, Lamborn KR, Kapadia A, Malec M, Berger MS, Stokoe D (2005) Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib. JNCI: J Natl Cancer Instit 97(12):880–887. https://doi.org/10.1093/jnci/dji161 CrossRef

16.

Noushmehr H, Weisenberger DJ, Diefes K, Phillips HS, Pujara K, Berman BP, Pan F, Pelloski CE, Sulman EP, Bhat KP, Verhaak RGW, Hoadley KA, Hayes DN, Perou CM, Schmidt HK, Ding L, Wilson RK, Van Den Berg D, Shen H, Bengtsson H, Neuvial P, Cope LM, Buckley J, Herman JG, Baylin SB, Laird PW, Aldape K (2010) Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 17(5):510–522. https://doi.org/10.1016/j.ccr.2010.03.017 CrossRefPubMedPubMedCentral

17.

Raab SS, Grzybicki DM, Janosky JE, Zarbo RJ, Meier FA, Jensen C, Geyer SJ (2005) Clinical impact and frequency of anatomic pathology errors in cancer diagnoses. Cancer 104(10):2205–2213. https://doi.org/10.1002/cncr.21431 CrossRefPubMed

18.

Gerlinger M, Rowan AJ, Horswell S, Math M, Larkin J, Endesfelder D, Gronroos E, Martinez P, Matthews N, Stewart A, Tarpey P, Varela I, Phillimore B, Begum S, McDonald NQ, Butler A, Jones D, Raine K, Latimer C, Santos CR, Nohadani M, Eklund AC, Spencer-Dene B, Clark G, Pickering L, Stamp G, Gore M, Szallasi Z, Downward J, Futreal PA, Swanton C (2012) Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366(10):883–892. https://doi.org/10.1056/NEJMoa1113205 CrossRefPubMedPubMedCentral

19.

Friedmann-Morvinski D (2014) Glioblastoma heterogeneity and cancer cell plasticity. Crit Rev Oncog 19(5):327–336. https://doi.org/10.1615/critrevoncog.2014011777 CrossRefPubMed

20.

Inda MM, Bonavia R, Seoane J (2014) Glioblastoma multiforme: a look inside its heterogeneous nature. Cancers (Basel) 6(1):226–239. https://doi.org/10.3390/cancers6010226 CrossRef

21.

Gevaert O, Mitchell LA, Achrol AS, Xu J, Echegaray S, Steinberg GK, Cheshier SH, Napel S, Zaharchuk G, Plevritis SK (2014) Glioblastoma multiforme: exploratory radiogenomic analysis by using quantitative image features. Radiology 273(1):168–174. https://doi.org/10.1148/radiol.14131731 CrossRefPubMed

22.

Zinn PO, Mahajan B, Sathyan P, Singh SK, Majumder S, Jolesz FA, Colen RR (2011) Radiogenomic mapping of edema/cellular invasion MRI-phenotypes in glioblastoma multiforme. PLoS One 6(10):e25451. https://doi.org/10.1371/journal.pone.0025451 CrossRefPubMedPubMedCentral

23.

Lambin P, Rios-Velazquez E, Leijenaar R, Carvalho S, van Stiphout RG, Granton P, Zegers CM, Gillies R, Boellard R, Dekker A, Aerts HJ (2012) Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer 48(4):441–446. https://doi.org/10.1016/j.ejca.2011.11.036 CrossRefPubMedPubMedCentral

24.

Djuricic GJ, Radulovic M, Sopta JP, Nikitovic M, Milosevic NT (2017) Fractal and gray level cooccurrence matrix computational analysis of primary osteosarcoma magnetic resonance images predicts the chemotherapy response. Front Oncol 7:246. https://doi.org/10.3389/fonc.2017.00246 CrossRefPubMedPubMedCentral

25.

Parekh V, Jacobs MA (2016) Radiomics: a new application from established techniques. Expert Rev Precis Med Drug Dev 1(2):207–226. https://doi.org/10.1080/23808993.2016.1164013 CrossRefPubMedPubMedCentral

26.

Haralick RM, Shanmugam K, Dinstein I (1973) Textural features of image classification. IEEE Trans Syst Man Cybern 3(6):610–621. https://doi.org/10.1109/TSMC.1973.4309314 CrossRef

27.

Czarnek N, Clark K, Peters KB, Mazurowski MA (2017) Algorithmic three-dimensional analysis of tumor shape in MRI improves prognosis of survival in glioblastoma: a multi-institutional study. J Neuro-Oncol 132(1):55–62. https://doi.org/10.1007/s11060-016-2359-7 CrossRef

28.

Mazurowski MA, Czarnek NM, Collins LM, Peters KB, Clark K (2016) Predicting outcomes in glioblastoma patients using computerized analysis of tumor shape - preliminary data. In: Progress in Biomedical Optics and Imaging - Proceedings of SPIE. https://doi.org/10.1117/12.2217098

29.

Ditmer A, Zhang B, Shujaat T, Pavlina A, Luibrand N, Gaskill-Shipley M, Vagal A (2018) Diagnostic accuracy of MRI texture analysis for grading gliomas. J Neuro-Oncol 140(3):583–589. https://doi.org/10.1007/s11060-018-2984-4 CrossRef

30.

Galloway MM (1975) Texture analysis using gray level run lengths. Comput Graphics Image Process 4(2):172–179. https://doi.org/10.1016/S0146-664X(75)800086 CrossRef

31.

Amadasun M, King R (1989) Textural features corresponding to textural properties. IEEE Trans Syst Man Cybern 19(5):1264–1274. https://doi.org/10.1109/21.44046 CrossRef

32.

Ojala T, Pietikäinen M, Mäenpää T (2002) Multiresolution gray-scale and rotation invariant texture classification with local binary patterns, vol 24. vol 7 %. J IEEE Trans Pattern Anal Mach. Intell. IEEE Computer Society. https://doi.org/10.1109/tpami.2002.1017623

33.

Ambrosini RD, Wang P, O'Dell WG (2010) Computer-aided detection of metastatic brain tumors using automated three-dimensional template matching. J Magn Reson Imaging 31(1):85–93. https://doi.org/10.1002/jmri.22009 CrossRefPubMedPubMedCentral

34.

Lowe DG (1999) Object recognition from local scale-invariant features. In: Proceedings of the Seventh IEEE International Conference on Computer Vision, 20–27 Sept. 1999. pp 1150–1157 vol.1152. https://doi.org/10.1109/ICCV.1999.790410

35.

Dalal N, Triggs B (2005) Histograms of oriented gradients for human detection. In: 2005 IEEE Computer Society Conference on Computer Vision and Pattern Recognition (CVPR'05), 20–25 June 2005. vol. 881. pp 886–893. https://doi.org/10.1109/CVPR.2005.177

36.

Mandelbrot BB, Freeman WH, Company (1983) The fractal geometry of nature. Henry Holt and Company

37.

Di Ieva A, Grizzi F, Jelinek H, Pellionisz AJ, Losa GA (2013) Fractals in the neurosciences, part I: general principles and basic neurosciences. Neuroscientist 20(4):403–417. https://doi.org/10.1177/1073858413513927 CrossRefPubMed

38.

Di Ieva A, Esteban FJ, Grizzi F, Klonowski W, Martín-Landrove M (2013) Fractals in the neurosciences, part II: clinical applications and future perspectives. Neuroscientist 21(1):30–43. https://doi.org/10.1177/1073858413513928 CrossRefPubMed

39.

Smitha KA, Gupta AK, Jayasree RS (2015) Fractal analysis: fractal dimension and lacunarity from MR images for differentiating the grades of glioma. Phys Med Biol 60(17):6937–6947. https://doi.org/10.1088/0031-9155/60/17/6937 CrossRefPubMed

40.

Lim JS (1990) Two-dimensional signal and image processing. Prentice-Hall, Inc.

41.

Gonzalez RC, Woods RE, Eddins SL (2004) Digital image processing using MATLAB. Pearson Education

42.

Aerts HJ, Velazquez ER, Leijenaar RT, Parmar C, Grossmann P, Carvalho S, Bussink J, Monshouwer R, Haibe-Kains B, Rietveld D, Hoebers F, Rietbergen MM, Leemans CR, Dekker A, Quackenbush J, Gillies RJ, Lambin P (2014) Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 5:4006. https://doi.org/10.1038/ncomms5006 CrossRefPubMed

43.

van Griethuysen JJM, Fedorov A, Parmar C, Hosny A, Aucoin N, Narayan V, Beets-Tan RGH, Fillion-Robin JC, Pieper S, Aerts H (2017) Computational Radiomics system to decode the radiographic phenotype. Cancer Res 77(21):e104–e107. https://doi.org/10.1158/0008-5472.Can-17-0339 CrossRefPubMedPubMedCentral

44.

Rizzo S, Botta F, Raimondi S, Origgi D, Fanciullo C, Morganti AG, Bellomi M (2018) Radiomics: the facts and the challenges of image analysis. Eur Radiol Exp 2(1):36–36. https://doi.org/10.1186/s41747-018-0068-z CrossRefPubMedPubMedCentral

45.

Earnest F, Kelly PJ, Scheithauer BW, Kall BA, Cascino TL, Ehman RL, Forbes GS, Axley PL (1988) Cerebral astrocytomas: histopathologic correlation of MR and CT contrast enhancement with stereotactic biopsy. Radiology 166(3):823–827. https://doi.org/10.1148/radiology.166.3.2829270 CrossRefPubMed

46.

Zhou M, Scott J, Chaudhury B, Hall L, Goldgof D, Yeom KW, Iv M, Ou Y, Kalpathy-Cramer J, Napel S, Gillies R, Gevaert O, Gatenby R (2018) Radiomics in brain tumor: image assessment, quantitative feature descriptors, and machine-learning approaches. Am J Neuroradiol 39(2):208–216. https://doi.org/10.3174/ajnr.A5391 CrossRefPubMedPubMedCentral

47.

Gatenby RA, Grove O, Gillies RJ (2013) Quantitative imaging in cancer evolution and ecology. Radiology 269(1):8–15. https://doi.org/10.1148/radiol.13122697 CrossRefPubMedPubMedCentral

48.

Zhou M, Hall L, Goldgof D, Gillies R, Gatenby R (2013) Survival time prediction of patients with glioblastoma multiforme tumors using spatial distance measurement, vol 8670. SPIE Medical Imaging. SPIE

49.

Cao Y, Tsien CI, Nagesh V, Junck L, Ten Haken R, Ross BD, Chenevert TL, Lawrence TS (2006) Survival prediction in high-grade gliomas by MRI perfusion before and during early stage of RT [corrected]. Int J Radiat Oncol Biol Phys 64(3):876–885. https://doi.org/10.1016/j.ijrobp.2005.09.001 CrossRefPubMed

50.

Zhou M, Hall L, Goldgof D, Russo R, Balagurunathan Y, Gillies R, Gatenby R (2014) Radiologically defined ecological dynamics and clinical outcomes in glioblastoma multiforme: preliminary results. Transl Oncol 7(1):5–13. https://doi.org/10.1593/tlo.13730 CrossRefPubMedPubMedCentral

51.

Chang PD, Malone HR, Bowden SG, Chow DS, Gill BJA, Ung TH, Samanamud J, Englander ZK, Sonabend AM, Sheth SA, McKhann GM 2nd, Sisti MB, Schwartz LH, Lignelli A, Grinband J, Bruce JN, Canoll P (2017) A multiparametric model for mapping cellularity in glioblastoma using radiographically localized biopsies. AJNR Am J Neuroradiol 38(5):890–898. https://doi.org/10.3174/ajnr.A5112 CrossRefPubMedPubMedCentral

52.

Gordillo N, Montseny E, Sobrevilla P (2013) State of the art survey on MRI brain tumor segmentation. Magn Reson Imaging 31(8):1426–1438. https://doi.org/10.1016/j.mri.2013.05.002 CrossRefPubMed

53.

Gibbs P, Buckley DL, Blackband SJ, Horsman A (1996) Tumour volume determination from MR images by morphological segmentation. Phys Med Biol 41(11):2437–2446. https://doi.org/10.1088/0031-9155/41/11/014 CrossRefPubMed

54.

Hojjatoleslami SA, Kittler J (1998) Region growing: a new approach. IEEE Trans Image Process 7(7):1079–1084. https://doi.org/10.1109/83.701170 CrossRefPubMed

55.

Mie S, Lakare S, Ming W, Kaufman A, Nakajima M (2000) A gradient magnitude based region growing algorithm for accurate segmentation. In: Proceedings 2000 International Conference on Image Processing (Cat. No.00CH37101), 10–13 Sept. 2000. vol.443, pp 448–451. https://doi.org/10.1109/ICIP.2000.899432

56.

Dam E, Loog M, Letteboer M (2004) Integrating automatic and interactive brain tumor segmentation. In: Proceedings of the 17th International Conference on Pattern Recognition, 2004. ICPR 2004., 26–26 Aug. 2004. vol 793, pp 790–793. https://doi.org/10.1109/ICPR.2004.1334647

57.

Kannan SR (2008) A new segmentation system for brain MR images based on fuzzy techniques. Appl Soft Comput 8(4):1599–1606. https://doi.org/10.1016/j.asoc.2007.10.025 CrossRef

58.

Iftekharuddin KM, Zheng J, Islam MA, Ogg RJ (2009) Fractal-based brain tumor detection in multimodal MRI. Appl Math Comput 207(1):23–41. https://doi.org/10.1016/j.amc.2007.10.063 CrossRef

59.

Bernal J, Kushibar K, Asfaw DS, Valverde S, Oliver A, Martí R, Lladó X (2019) Deep convolutional neural networks for brain image analysis on magnetic resonance imaging: a review. Artif Intell Med 95:64–81. https://doi.org/10.1016/j.artmed.2018.08.008 CrossRefPubMed

60.

Zikic D, Ioannou Y, Brown M, Criminisi A (2014) Segmentation of brain tumor tissues with convolutional neural networks. In: Proceedings MICCAI-BRATS. pp 36–39

61.

Brébisson Ad, Montana G (2015) Deep neural networks for anatomical brain segmentation. In: 2015 IEEE Conference on Computer Vision and Pattern Recognition Workshops (CVPRW), 7–12 June 2015. pp 20–28. https://doi.org/10.1109/CVPRW.2015.7301312

62.

Havaei M, Davy A, Warde-Farley D, Biard A, Courville A, Bengio Y, Pal C, Jodoin P-M, Larochelle H (2017) Brain tumor segmentation with deep neural networks. Med Image Anal 35:18–31. https://doi.org/10.1016/j.media.2016.05.004 CrossRefPubMed

63.

Zhang W, Li R, Deng H, Wang L, Lin W, Ji S, Shen D (2015) Deep convolutional neural networks for multi-modality isointense infant brain image segmentation. NeuroImage 108:214–224. https://doi.org/10.1016/j.neuroimage.2014.12.061 CrossRefPubMed

64.

Lyksborg M, Puonti O, Agn M, Larsen R (2015) An ensemble of 2D convolutional neural networks for tumor segmentation. In: Paulsen RR, Pedersen KS (eds) Image Analysis, Cham, 2015. Springer International Publishing, p 201–211

65.

Li W, Wang G, Fidon L, Ourselin S, Cardoso MJ, Vercauteren T (2017) On the compactness, efficiency, and representation of 3D convolutional networks: brain parcellation as a pretext task. In: Niethammer M, Styner M, Aylward S, et al (eds) Information Processing in Medical Imaging, Cham, 2017. Springer International Publishing, p 348–360

66.

Kamnitsas K, Ledig C, Newcombe VFJ, Simpson JP, Kane AD, Menon DK, Rueckert D, Glocker B (2017) Efficient multi-scale 3D CNN with fully connected CRF for accurate brain lesion segmentation. Med Image Anal 36:61–78. https://doi.org/10.1016/j.media.2016.10.004 CrossRefPubMed

67.

McInerney T, Terzopoulos D (1996) Deformable models in medical image analysis: a survey. Med Image Anal 1(2):91–108. https://doi.org/10.1016/S1361-8415(96)80007-7 CrossRefPubMed

68.

Wu Y, Zhao Z, Wu W, Lin Y, Wang M (2019) Automatic glioma segmentation based on adaptive superpixel. BMC Med Imaging 19(1):73. https://doi.org/10.1186/s12880-019-0369-6 CrossRefPubMedPubMedCentral

69.

Madabhushi A, Udupa JK (2006) New methods of MR image intensity standardization via generalized scale. Med Phys 33(9):3426–3434. https://doi.org/10.1118/1.2335487 CrossRefPubMed

70.

Di Ieva A, Matula C, Grizzi F, Grabner G, Trattnig S, Tschabitscher M (2012) Fractal analysis of the susceptibility weighted imaging patterns in malignant brain tumors during antiangiogenic treatment: technical report on four cases serially imaged by 7 T magnetic resonance during a period of four weeks. World Neurosurg 77(5-6):785.e711–785.e721. https://doi.org/10.1016/j.wneu.2011.09.006 CrossRef

71.

Sottoriva A, Spiteri I, Piccirillo SGM, Touloumis A, Collins VP, Marioni JC, Curtis C, Watts C, Tavaré S (2013) Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc Natl Acad Sci U S A 110(10):4009–4014. https://doi.org/10.1073/pnas.1219747110 CrossRefPubMedPubMedCentral

72.

Georgiadis P, Cavouras D, Kalatzis I, Glotsos D, Athanasiadis E, Kostopoulos S, Sifaki K, Malamas M, Nikiforidis G, Solomou E (2009) Enhancing the discrimination accuracy between metastases, gliomas and meningiomas on brain MRI by volumetric textural features and ensemble pattern recognition methods. Magn Reson Imaging 27(1):120–130. https://doi.org/10.1016/j.mri.2008.05.017 CrossRefPubMed

73.

Yang D, Rao G, Martinez J, Veeraraghavan A, Rao A (2015) Evaluation of tumor-derived MRI-texture features for discrimination of molecular subtypes and prediction of 12-month survival status in glioblastoma. Med Phys 42(11):6725–6735. https://doi.org/10.1118/1.4934373 CrossRefPubMedPubMedCentral

74.

Molina D, Perez-Beteta J, Luque B, Arregui E, Calvo M, Borras JM, Lopez C, Martino J, Velasquez C, Asenjo B, Benavides M, Herruzo I, Martinez-Gonzalez A, Perez-Romasanta L, Arana E, Perez-Garcia VM (2016) Tumour heterogeneity in glioblastoma assessed by MRI texture analysis: a potential marker of survival. Br J Radiol 89(1064):20160242. https://doi.org/10.1259/bjr.20160242 CrossRefPubMedPubMedCentral

75.

Chang K, Zhang B, Guo X, Zong M, Rahman R, Sanchez D, Winder N, Reardon DA, Zhao B, Wen PY, Huang RY (2016) Multimodal imaging patterns predict survival in recurrent glioblastoma patients treated with bevacizumab. Neuro-Oncology 18(12):1680–1687. https://doi.org/10.1093/neuonc/now086 CrossRefPubMedPubMedCentral

76.

Sanghani P, Ang BT, King NKK, Ren H (2018) Overall survival prediction in glioblastoma multiforme patients from volumetric, shape and texture features using machine learning. Surg Oncol 27(4):709–714. https://doi.org/10.1016/j.suronc.2018.09.002 CrossRefPubMed

77.

Lao J, Chen Y, Li Z-C, Li Q, Zhang J, Liu J, Zhai G (2017) A deep learning-based radiomics model for prediction of survival in glioblastoma multiforme. Sci Rep 7(1):10353. https://doi.org/10.1038/s41598-017-10649-8 CrossRefPubMedPubMedCentral

78.

Li Q, Bai H, Chen Y, Sun Q, Liu L, Zhou S, Wang G, Liang C, Li Z-C (2017) A fully-automatic multiparametric radiomics model: towards reproducible and prognostic imaging signature for prediction of overall survival in glioblastoma multiforme. Sci Rep 7(1):14331. https://doi.org/10.1038/s41598-017-14753-7 CrossRefPubMedPubMedCentral

79.

Prasanna P, Patel J, Partovi S, Madabhushi A, Tiwari P (2017) Radiomic features from the peritumoral brain parenchyma on treatment-naive multi-parametric MR imaging predict long versus short-term survival in glioblastoma multiforme: preliminary findings. Eur Radiol 27(10):4188–4197. https://doi.org/10.1007/s00330-016-4637-3 CrossRefPubMed

80.

Bahrami N, Piccioni D, Karunamuni R, Chang YH, White N, Delfanti R, Seibert TM, Hattangadi-Gluth JA, Dale A, Farid N, McDonald CR (2018) Edge contrast of the FLAIR hyperintense region predicts survival in patients with high-grade gliomas following treatment with bevacizumab. AJNR Am J Neuroradiol 39(6):1017–1024. https://doi.org/10.3174/ajnr.A5620 CrossRefPubMedPubMedCentral

81.

Bisdas S, Shen HC, Thust S, Katsaros V, Stranjalis G, Boskos C, Brandner S, Zhang JG (2018) Texture analysis- and support vector machine-assisted diffusional kurtosis imaging may allow in vivo gliomas grading and IDH-mutation status prediction: a preliminary study Scientific Reports 8. https://doi.org/10.1038/s41598-018-24438-4

82.

Bae S, Choi YS, Ahn SS, Chang JH, Kang SG, Kim EH, Kim SH, Lee SK (2018) Radiomic MRI phenotyping of glioblastoma: improving survival prediction. Radiology 289(3):797–806. https://doi.org/10.1148/radiol.2018180200 CrossRefPubMed

83.

Bahrami N, Hartman SJ, Chang YH, Delfanti R, White NS, Karunamuni R, Seibert TM, Dale AM, Hattangadi-Gluth JA, Piccioni D, Farid N, McDonald CR (2018) Molecular classification of patients with grade II/III glioma using quantitative MRI characteristics. J Neuro-Oncol 139(3):633–642. https://doi.org/10.1007/s11060-018-2908-3 CrossRef

84.

Chaddad A, Sabri S, Niazi T, Abdulkarim B (2018) Prediction of survival with multi-scale radiomic analysis in glioblastoma patients. Med Biol Eng Comput 56(12):2287–2300. https://doi.org/10.1007/s11517-018-1858-4 CrossRefPubMed

85.

Darbar A, Waqas M, Enam SF, Mahmood SD (2018) Use of preoperative apparent diffusion coefficients to predict brain tumor grade. Cureus 10(3):e2284. https://doi.org/10.7759/cureus.2284 CrossRefPubMedPubMedCentral

86.

Osman AFI (2019) A multi-parametric MRI-based radiomics signature and a practical ML model for stratifying glioblastoma patients based on survival toward precision oncology. Front Comput Neurosci 13:58. https://doi.org/10.3389/fncom.2019.00058 CrossRefPubMedPubMedCentral

87.

Petrujkic K, Milosevic N, Rajkovic N, Stanisavljevic D, Gavrilovic S, Dzelebdzic D, Ilic R, Di Ieva A, Maksimovic R (2019) Computational quantitative MR image features - a potential useful tool in differentiating glioblastoma from solitary brain metastasis. Eur J Radiol 119:108634. https://doi.org/10.1016/j.ejrad.2019.08.003 CrossRefPubMed

88.

Yang Y, Yan LF, Zhang X, Nan HY, Hu YC, Han Y, Zhang J, Liu ZC, Sun YZ, Tian Q, Yu Y, Sun Q, Wang SY, Zhang X, Wang W, Cui GB (2019) Optimizing texture retrieving model for multimodal MR image-based support vector machine for classifying glioma. J Magn Reson Imaging 49(5):1263–1274. https://doi.org/10.1002/jmri.26524 CrossRefPubMed

89.

Schoenegger K, Oberndorfer S, Wuschitz B, Struhal W, Hainfellner J, Prayer D, Heinzl H, Lahrmann H, Marosi C, Grisold W (2009) Peritumoral edema on MRI at initial diagnosis: an independent prognostic factor for glioblastoma? Eur J Neurol 16(7):874–878. https://doi.org/10.1111/j.1468-1331.2009.02613.x CrossRefPubMed

90.

Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, Lang FF, McCutcheon I, Hassenbusch SJ, Holland E, Hess K, Michael C, Miller D, Sawaya R (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95(2):190–198. https://doi.org/10.3171/jns.2001.95.2.0190 CrossRefPubMed

91.

Skogen K, Schulz A, Dormagen JB, Ganeshan B, Helseth E, Server A (2016) Diagnostic performance of texture analysis on MRI in grading cerebral gliomas. Eur J Radiol 85(4):824–829. https://doi.org/10.1016/j.ejrad.2016.01.013 CrossRefPubMed

92.

Macyszyn L, Akbari H, Pisapia JM, Da X, Attiah M, Pigrish V, Bi Y, Pal S, Davuluri RV, Roccograndi L, Dahmane N, Martinez-Lage M, Biros G, Wolf RL, Bilello M, O'Rourke DM, Davatzikos C (2016) Imaging patterns predict patient survival and molecular subtype in glioblastoma via machine learning techniques. Neuro-Oncology 18(3):417–425. https://doi.org/10.1093/neuonc/nov127 CrossRefPubMed

93.

Lahmiri S, Boukadoum M (2012) Automatic brain MR images diagnosis based on edge fractal dimension and spectral energy signature. Conf Proc IEEE Eng Med Biol Soc 2012:6243–6246. https://doi.org/10.1109/embc.2012.6347421 CrossRef

94.

Lahmiri S, Boukadoum M, Di Ieva A (2014) Detrended fluctuation analysis of brain hemisphere magnetic resonnance images to detect cerebral arteriovenousmalformations. In: 2014 IEEE International Symposium on Circuits and Systems (ISCAS), 1–5 June 2014. pp 2409–2412 https://doi.org/10.1109/ISCAS.2014.6865658

95.

Lahmiri S, Boukadoum M (2013) Automatic detection of Alzheimer disease in brain magnetic resonance images using fractal features. In: 2013 6th International IEEE/EMBS Conference on Neural Engineering (NER), 6–8 Nov. 2013. p 1505–1508. https://doi.org/10.1109/NER.2013.6696231

96.

Di Ieva A (Ed.) (2016) The fractal geometry of the brain. Springer, New York

97.

Iftekharuddin KM, Jia W, Marsh R (2003) Fractal analysis of tumor in brain MR images. Mach Vis Appl 13(5):352–362. https://doi.org/10.1007/s00138-002-0087-9 CrossRef

98.

Zook JM, Iftekharuddin KM (2005) Statistical analysis of fractal-based brain tumor detection algorithms. Magn Reson Imaging 23(5):671–678. https://doi.org/10.1016/j.mri.2005.04.002 CrossRefPubMed

99.

Di Ieva A, Göd S, Grabner G, Grizzi F, Sherif C, Matula C, Tschabitscher M, Trattnig S (2013) Three-dimensional susceptibility-weighted imaging at 7 T using fractal-based quantitative analysis to grade gliomas. Neuroradiology 55(1):35–40. https://doi.org/10.1007/s00234-012-1081-1 CrossRefPubMed

100.

Kristin RS, Alvord EC, Murray JD (2003) Dynamics of a model for brain tumors reveals a small window for therapeutic intervention. Discrete Contin Dynam Syst B 4(1):289–295. https://doi.org/10.3934/dcdsb.2004.4.289 CrossRef

101.

Sedivy R (1996) Fractal tumours: their real and virtual images. Wien Klin Wochenschr 108(17):547–551PubMed

102.

Di Ieva A (2010) Angioarchitectural morphometrics of brain tumors: are there any potential histopathological biomarkers? Microvasc Res 80(3):522–533. https://doi.org/10.1016/j.mvr.2010.09.005 CrossRefPubMed

103.

Di Ieva A, Grizzi F, Ceva-Grimaldi G, Russo C, Gaetani P, Aimar E, Levi D, Pisano P, Tancioni F, Nicola G, Tschabitscher M, Dioguardi N, Baena RRY (2007) Fractal dimension as a quantitator of the microvasculature of normal and adenomatous pituitary tissue. J Anat 211(5):673–680. https://doi.org/10.1111/j.1469-7580.2007.00804.x CrossRefPubMedPubMedCentral

104.

Di Ieva A, Grizzi F, Gaetani P, Goglia U, Tschabitscher M, Mortini P, Rodriguez y Baena R (2008) Euclidean and fractal geometry of microvascular networks in normal and neoplastic pituitary tissue. Neurosurg Rev 31(3):271–281. https://doi.org/10.1007/s10143-008-01277 CrossRefPubMed

105.

Di Ieva A, Grizzi F, Tschabitscher M, Colombo P, Casali M, Simonelli M, Widhalm G, Muzzio PC, Matula C, Chiti A, Rodriguez y Baena R (2010) Correlation of microvascular fractal dimension with positron emission tomography [(11)C]-methionine uptake in glioblastoma multiforme: preliminary findings. Microvasc Res 80(2):267–273. https://doi.org/10.1016/j.mvr.2010.04.003 CrossRefPubMed

106.

Di Ieva A, Bruner E, Widhalm G, Minchev G, Tschabitscher M, Grizzi F (2012) Computer-assisted and fractal-based morphometric assessment of microvascularity in histological specimens of gliomas. Sci Rep 2(1):429. https://doi.org/10.1038/srep00429 CrossRefPubMedPubMedCentral

107.

Bates DW, Saria S, Ohno-Machado L, Shah A, Escobar G (2014) Big data in health care: using analytics to identify and manage high-risk and high-cost patients. Health Aff 33(7):1123–1131. https://doi.org/10.1377/hlthaff.2014.0041 CrossRef

108.

Abrol S, Kotrotsou A, Salem A, Zinn PO, Colen RR (2017) Radiomic phenotyping in brain cancer to unravel hidden information in medical images. Top Magn Reson Imaging 26(1):43–53. https://doi.org/10.1097/rmr.0000000000000117 CrossRefPubMed

109.

Cancer Genome Atlas Research Network (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455(7216):1061–1068. https://doi.org/10.1038/nature07385 CrossRef

110.

Prior FW, Clark K, Commean P, Freymann J, Jaffe C, Kirby J, Moore S, Smith K, Tarbox L, Vendt B, Marquez G (2013) TCIA: an information resource to enable open science. Conf Proc IEEE Eng Med Biol Soc 2013:1282–1285. https://doi.org/10.1109/embc.2013.6609742 CrossRefPubMedCentral

111.

Kalpathy-Cramer J, Freymann JB, Kirby JS, Kinahan PE, Prior FW (2014) Quantitative imaging network: data sharing and competitive algorithmvalidation leveraging the cancer imaging archive. Transl Oncol 7(1):147–152. https://doi.org/10.1593/tlo.13862 CrossRefPubMedPubMedCentral

112.

Heilbrun ME (2013) Evaluating RadLex and real world radiology reporting: are we there yet? Acad Radiol 20(11):1327–1328. https://doi.org/10.1016/j.acra.2013.09.011 CrossRefPubMed

113.

Tibshirani R (1996) Regression shrinkage and selection via the lasso. J R Stat Soc Ser B Methodol 58(1):267–288

114.

Gevaert O, Xu J, Hoang CD, Leung AN, Xu Y, Quon A, Rubin DL, Napel S, Plevritis SK (2012) Non-small cell lung cancer: identifying prognostic imaging biomarkers by leveraging public gene expression microarray data--methods and preliminary results. Radiology 264(2):387–396. https://doi.org/10.1148/radiol.12111607 CrossRefPubMedPubMedCentral

115.

Shen W, Zhou M, Yang F, Dong D, Yang C, Zang Y, Tian J (2016) Learning from experts: developing transferable deep features for patient-level lung cancer prediction. In: Ourselin S, Joskowicz L, Sabuncu MR, Unal G, Wells W (eds) Medical Image Computing and Computer-Assisted Intervention – MICCAI 2016, Cham, 2016. Springer International Publishing, p 124–131

116.

Mamoshina P, Vieira A, Putin E, Zhavoronkov A (2016) Applications of deep learning in biomedicine. Mol Pharm 13(5):1445–1454. https://doi.org/10.1021/acs.molpharmaceut.5b00982 CrossRefPubMed

117.

Chu HH, Choi SH, Ryoo I, Kim SC, Yeom JA, Shin H, Jung SC, Lee AL, Yoon TJ, Kim TM, Lee S-H, Park C-K, Kim J-H, Sohn C-H, Park S-H, Kim IH (2013) Differentiation of true progression from pseudoprogression in glioblastoma treated with radiation therapy and concomitant temozolomide: comparison study of standard and high-b-value diffusion-weighted imaging. Radiology 269(3):831–840. https://doi.org/10.1148/radiol.13122024 CrossRefPubMed

118.

Chang PD, Chow DS, Yang PH, Filippi CG, Lignelli A (2017) Predicting glioblastoma recurrence by early changes in the apparent diffusion coefficient value and signal intensity on FLAIR images. AJR Am J Roentgenol 208(1):57–65. https://doi.org/10.2214/ajr.16.16234 CrossRefPubMed

119.

Ellingson BM, Cloughesy TF, Lai A, Nghiemphu PL, Mischel PS, Pope WB (2011) Quantitative volumetric analysis of conventional MRI response in recurrent glioblastoma treated with bevacizumab. Neuro-Oncology 13(4):401–409. https://doi.org/10.1093/neuonc/noq206 CrossRefPubMedPubMedCentral

120.

Zhou M, Hall LO, Goldgof DB, Russo R, Gillies RJ, Gatenby RA (2015) Decoding brain cancer dynamics: a quantitative histogram-based approach using temporal MRI. In: Progress in Biomedical Optics and Imaging - Proceedings of SPIE. https://doi.org/10.1117/12.2075545

121.

Hygino da Cruz LC, Rodriguez I, Domingues RC, Gasparetto EL, Sorensen AG (2011) Pseudoprogression and pseudoresponse: imaging challenges in the assessment of posttreatment glioma. Am J Neuroradiol 32(11):1978–1985. https://doi.org/10.3174/ajnr.A2397 CrossRefPubMedPubMedCentral

122.

Wardlaw G, Wong R, Noseworthy MD (2008) Identification of intratumour low frequency microvascular components via BOLD signal fractal dimension mapping. Phys Med 24(2):87–91. https://doi.org/10.1016/j.ejmp.2008.01.006 CrossRefPubMed

123.

Michallek F, Dewey M (2014) Fractal analysis in radiological and nuclear medicine perfusion imaging: a systematic review. Eur Radiol 24(1):60–69. https://doi.org/10.1007/s00330-013-2977-9 CrossRefPubMed

Title: Radiomics in gliomas: clinical implications of computational modeling and fractal-based analysis
Authors: Kevin Jang
Carlo Russo
Antonio Di Ieva
Publication date: 01-07-2020
Publisher: Springer Berlin Heidelberg
Keywords: Glioblastoma
Glioma
Glioma
Glioblastoma
Glioblastoma
Glioma
Published in: Neuroradiology / Issue 7/2020
Print ISSN: 0028-3940
Electronic ISSN: 1432-1920
DOI: https://doi.org/10.1007/s00234-020-02403-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Radiomics in gliomas: clinical implications of computational modeling and fractal-based analysis

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 7/2020

Differentiation of high-grade from low-grade diffuse gliomas using diffusion-weighted imaging: a comparative study of mono-, bi-, and stretched-exponential diffusion models

Primary endovascular treatment for acute ischemic stroke in teenage patients: a short case series

Endovascular thrombectomy for tandem acute ischemic stroke associated with cervical artery dissection: a systematic review and meta-analysis

The diagnostic role of diffusional kurtosis imaging in glioma grading and differentiation of gliomas from other intra-axial brain tumours: a systematic review with critical appraisal and meta-analysis

Virtual meetings: a temporary choice or an effective opportunity for the future?

Radiology workload in clinical implementation of thrombectomy for acute ischemic stroke: experience from The Netherlands